Advances in I-O Biomarkers
Nov 07, 2024•53 min•Season 4Ep. 8
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
While the rapid evolution of I-O continues to bring unprecedented change to the way cancer is treated, there are significant gaps impacting the laboratory team regarding the examination of resection specimens following neoadjuvant immunotherapy and staying abreast of advances in I-O biomarker testing.
This episode discusses advances in I-O biomarker testing, advantages and limitations of some key I-O biomarkers, and practical ways that pathologists and laboratory professionals can improve their I-O biomarker testing workflows to optimize patient care.
Topics discussed include:
- Recent advances in immune-oncology (I-O) biomarker testing
- Advantages and limitations of IO biomarkers
- Addressing challenges related to IO biomarkers
- Improving IO biomarker workflows
- Best practices for collaboration with the multidisciplinary cancer care team
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast